Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin in certain areas may also occur. Under certain circumstances, an adrenal crisis may occur with low blood pressure, vomiting, lower back pain, and loss of consciousness. An adrenal crisis can be triggered by stress, such as from an injury, surgery, or infection.
This report contains market size and forecasts of Addison's Disease Treatment in Global, including the following market information:
Global Addison's Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Addison's Disease Treatment market was valued at 1190 million in 2021 and is projected to reach US$ 1586.3 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Corticosteroid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Addison's Disease Treatment include Pfizer, GlaxoSmithKline, Takeda, Abbott Laboratories, Merck, Boehringer Ingelheim, Amgen and Lupin Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Addison's Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Addison's Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Addison's Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Oral Corticosteroid
Corticosteroid Injections
Global Addison's Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Addison's Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Addison's Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Addison's Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Addison's Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Addison's Disease Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GlaxoSmithKline
Takeda
Abbott Laboratories
Merck
Boehringer Ingelheim
Amgen
Lupin Pharmaceuticals